{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T11:47:04Z","timestamp":1789904824420,"version":"4.0.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2007,1,20]],"date-time":"2007-01-20T00:00:00Z","timestamp":1169251200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Metab Brain Dis"],"published-print":{"date-parts":[[2007,2,28]]},"DOI":"10.1007\/s11011-006-9041-2","type":"journal-article","created":{"date-parts":[[2007,1,19]],"date-time":"2007-01-19T17:16:17Z","timestamp":1169226977000},"page":"51-65","source":"Crossref","is-referenced-by-count":43,"title":["5-Oxoproline Reduces Non-Enzymatic Antioxidant Defenses in vitro in Rat Brain"],"prefix":"10.1007","volume":"22","author":[{"given":"Carolina D.","family":"Pederzolli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c2ngela M.","family":"Sgaravatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9sar A.","family":"Braum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina C.","family":"Prestes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni K.","family":"Zorzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirian B.","family":"Sgarbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela T. S.","family":"Wyse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00f3vis M. D.","family":"Wannmacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moacir","family":"Wajner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos S.","family":"Dutra-Filho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,1,20]]},"reference":[{"key":"9041_CR1","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0076-6879(84)05016-3","volume":"105","author":"H Aebi","year":"1984","unstructured":"Aebi H (1984) Catalase in vitro. Meth Enzymol 105:121\u2013126","journal-title":"Meth Enzymol"},{"key":"9041_CR2","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0304-3940(01)01636-6","volume":"302","author":"MY Aksenov","year":"2001","unstructured":"Aksenov MY, Markesbery WR (2001) Change in thiol content and expression of glutathione redox system gene in the hippocampus and cerebellum in Alzheimer's disease. Neurosci Lett 302:141\u2013145","journal-title":"Neurosci Lett"},{"key":"9041_CR3","first-page":"85","volume":"16","author":"D Barone","year":"1990","unstructured":"Barone D, Spignoli G (1990) Investigations on the binding properties of the nootropic agent pyroglutamic acid. Drugs Exp Clin Res 16:85\u201399","journal-title":"Drugs Exp Clin Res"},{"key":"9041_CR4","first-page":"1533","volume":"2","author":"JP Bennet Jr","year":"1973","unstructured":"Bennet Jr JP, Logan WJ, Snyder SH (1973) Amino acids as central nervous transmitters: the influence of ions, amino acid analogues, and ontogeny on transport systems for l-glutamic and aspartic acids and glycine into central nervous synaptosomes. J Neurochem 2:1533\u20131550","journal-title":"J Neurochem"},{"key":"9041_CR5","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1093\/hmg\/6.7.1147","volume":"6","author":"N Dahl","year":"1997","unstructured":"Dahl N, Pigg M, Ristoff E, Gali R, Carlsson B, Mannervik B, Larsson A, Board P (1997) Missense mutations in the human glutathione synthetase gene result in severe metabolic acidosis, 5-oxoprolinuria, hemolytic anemia and neurological dysfunction. Hum Mol Genet 6:1147\u20131152","journal-title":"Hum Mol Genet"},{"key":"9041_CR6","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/0028-3908(85)90043-7","volume":"24","author":"N Dusticier","year":"1985","unstructured":"Dusticier N, Kerkerian L, Errami M, Nieoullon A (1985) Effects of pyroglutamic acid on corticostriatal glutamatergic transmission. Neuropharmacology 24:903\u2013908","journal-title":"Neuropharmacology"},{"key":"9041_CR7","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/0009-8981(72)90359-2","volume":"48","author":"L Eldjarn","year":"1972","unstructured":"Eldjarn L, Jellum E, Stokke O (1972) Pyroglutamic aciduria: Studies on the enzymic block and on the metabolic origin of pyroglutamic acid. Clin Chim Acta 48:461\u2013476","journal-title":"Clin Chim Acta"},{"key":"9041_CR8","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/0009-8981(73)90227-1","volume":"49","author":"L Eldjarn","year":"1973","unstructured":"Eldjarn L, Jellum E, Stokke O (1973) Pyroglutamic aciduria: rate of formation and degradation of pyroglutamate. Clin Chim Acta 49:311\u2013323","journal-title":"Clin Chim Acta"},{"key":"9041_CR9","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0009-8981(73)90284-2","volume":"49","author":"M Escobedo","year":"1973","unstructured":"Escobedo M, Cravioto J (1973) Studies on the malabsorption syndromes inhibition of Na+-K+-ATPase of small intestine microvilli by pyrrolidone carboxylic acid. Clin Chim Acta 49:147\u2013151","journal-title":"Clin Chim Acta"},{"key":"9041_CR10","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/0076-6879(90)86134-H","volume":"186","author":"H Esterbauer","year":"1990","unstructured":"Esterbauer H, Cheeseman KH (1990) Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. Meth Enzymol 186:407\u2013421","journal-title":"Meth Enzymol"},{"key":"9041_CR11","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1006\/abbi.2001.2292","volume":"388","author":"P Evelson","year":"2001","unstructured":"Evelson P, Travacio M, Repetto M, Escobar J, Llesuy SF, Lissi E (2001) Evaluation of total reactive antioxidant potential (TRAP) of tissue homogenates and their cytosols. Arch Biochem Biophys 388:261\u2013266","journal-title":"Arch Biochem Biophys"},{"key":"9041_CR12","doi-asserted-by":"crossref","first-page":"685","DOI":"10.2165\/00002512-200118090-00004","volume":"18","author":"B Halliwell","year":"2001","unstructured":"Halliwell B (2001) Role of free radicals in the neurodegenerative diseases. Therapeutic implications for antioxidant treatment. Drug Aging 18:685\u2013716","journal-title":"Drug Aging"},{"key":"9041_CR13","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/sj.bjp.0705776","volume":"142","author":"B Halliwell","year":"2004","unstructured":"Halliwell B, Whiteman M (2004) Measuring reactive species and oxidative damage in vivo in cell culture: how should you do it and what do the results mean? Brit J Pharmacol 142:231\u2013255","journal-title":"Brit J Pharmacol"},{"key":"9041_CR14","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1007\/BF00711898","volume":"16","author":"GF Hoffmann","year":"1993","unstructured":"Hoffmann GF, Meier-Augenstein W, St\u00f6ckler S, Surtees R, Rating D, Nyhan WL (1993) Physiology and pathophysiology of organic acids in cerebrospinal fluid. J Inher Metab Dis 16:648\u2013699","journal-title":"J Inher Metab Dis"},{"key":"9041_CR15","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0022-3476(94)70309-4","volume":"124","author":"A Jain","year":"1994","unstructured":"Jain A, Buist NRM, Kennaway NG, Powell BR, Auld PA, Martensson J (1994) Effect of ascorbate or N-acetylcysteine treatment in a patient with hereditary glutathione synthetase deficiency. J Pediatr 124:229\u2013233","journal-title":"J Pediatr"},{"key":"9041_CR16","doi-asserted-by":"crossref","first-page":"327","DOI":"10.3109\/00365517009046241","volume":"26","author":"E Jellum","year":"1970","unstructured":"Jellum E, Kluge T, Borrensen HC, Stokke O, Eldjarn I (1970) Pyroglutamic aciduria: a new inborn error of metabolism. Scand J Clin Lab Invest 26:327\u2013335","journal-title":"Scand J Clin Lab Invest"},{"key":"9041_CR17","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1055\/s-2008-1052557","volume":"16","author":"A Larsson","year":"1985","unstructured":"Larsson A, Wachtmeister L, von Wendt L, Andersson R, Hagenfeldt L, Herrin KM (1985) Ophtalmological psychometric and therapeutic investigation in two sisters with hereditary glutathione synthetase deficiency (5-oxoprolinuria). Neuropediatrics 16:131\u2013136","journal-title":"Neuropediatrics"},{"key":"9041_CR18","first-page":"2205","volume-title":"The metabolic and molecular bases of inherited disease","author":"A Larsson","year":"2001","unstructured":"Larsson A, Anderson ME (2001) Glutathione synthetase deficiency and other disorders of the \u03b3-glutamyl cycle. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds), The metabolic and molecular bases of inherited disease. McGraw-Hill, New York, pp 2205\u20132216"},{"key":"9041_CR19","first-page":"63","volume":"2","author":"E Lissi","year":"1986","unstructured":"Lissi E, Caceres T, Videla LA (1986) Visible chemiluminescence from rat brain homogenates undergoing autoxidation. I effect of additives and products accumulation. Free Radic Biol Med 2:63\u201369","journal-title":"Free Radic Biol Med"},{"key":"9041_CR20","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3109\/10715769209079523","volume":"17","author":"E Lissi","year":"1992","unstructured":"Lissi E, Pascual C, Del Castillo MD (1992) Luminol luminescence induced by 2,2\u2032-azo-bis-(2-amidinopropane) thermolysis. Free Radic Res Commun 17:299\u2013311","journal-title":"Free Radic Res Commun"},{"key":"9041_CR21","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0891-5849(94)00117-3","volume":"18","author":"E Lissi","year":"1995","unstructured":"Lissi E, Salim-Hanna M, Pascual C, Del Castillo MD (1995) Evaluation of total antioxidant potential (TRAP) and total antioxidant reactivity from luminol-enhanced chemiluminescence measurements. Free Radic Biol Med 18:153\u2013158","journal-title":"Free Radic Biol Med"},{"key":"9041_CR22","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1177\/030089168507100305","volume":"71","author":"SF Llesuy","year":"1985","unstructured":"Llesuy SF, Milei J, Molina H, Boveris A, Milei S (1985) Comparison of lipid peroxidation and myocardial damage induced by adriamycin and 4\u2032-epiadriamycin in mice. Tumori 71:241\u2013249","journal-title":"Tumori"},{"key":"9041_CR23","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","volume":"193","author":"OH Lowry","year":"1951","unstructured":"Lowry OH, Rosebrough NJ, Lewis-Farr A, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265\u2013275","journal-title":"J Biol Chem"},{"key":"9041_CR24","first-page":"243","volume-title":"Pyrogallol autoxidation In Handbook for Oxygen Radical Research","author":"SL Marklund","year":"1985","unstructured":"Marklund SL (1985) Pyrogallol autoxidation in handbook for oxygen radical research. CRC Press, Boca Raton, pp 243\u2013247"},{"key":"9041_CR25","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0009-8981(81)90189-3","volume":"111","author":"S Marstein","year":"1981","unstructured":"Marstein S, Jellum E, Nesbakken R, Perry TL (1981) Biochemical investigations of biopsied brain tissue and autopsied organs from a patient with pyroglutamic acidemia (5-oxoprolinemia). Clin Chim Acta 111:219\u2013228","journal-title":"Clin Chim Acta"},{"key":"9041_CR26","doi-asserted-by":"crossref","first-page":"247","DOI":"10.7326\/0003-4819-81-2-247","volume":"81","author":"A Meister","year":"1974","unstructured":"Meister A (1974) The \u03b3-glutamyl cycle diseases associated with specific deficiencies. Annals Intern Med 81:247\u2013253","journal-title":"Annals Intern Med"},{"key":"9041_CR27","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0163-7258(91)90076-X","volume":"51","author":"A Meister","year":"1991","unstructured":"Meister A (1991) Glutathione deficiency produced by inhibition of its synthesis, and its reversal; applications in research and therapy. Pharmacol Ther 51:155\u2013194","journal-title":"Pharmacol Ther"},{"key":"9041_CR28","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/S0006-2952(03)00083-2","volume":"65","author":"O Myhre","year":"2003","unstructured":"Myhre O, Andersen JM, Aarnes H, Fonnum F (2003) Evaluation of the probes 2\u2032,7\u2032-dichlorofluorescin diacetate luminol and lucigenin as indicators of reactive species formation. Biochem Pharmacol 65:1575\u20131582","journal-title":"Biochem Pharmacol"},{"key":"9041_CR29","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0005-2728(98)00123-6","volume":"1366","author":"DG Nicholls","year":"1998","unstructured":"Nicholls DG, Budd SL (1998) Mitochondria and neuronal glutamate excitotoxicity. Biochim Biophys Acta 1366:97\u2013112","journal-title":"Biochim Biophys Acta"},{"key":"9041_CR30","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1007\/s00018-005-5163-7","volume":"62","author":"R Njalsson","year":"2005","unstructured":"Njalsson R (2005) Glutathione synthetase deficiency. Cell Mol Life Sci 62:1938\u20131945","journal-title":"Cell Mol Life Sci"},{"key":"9041_CR31","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1080\/08035250410025285","volume":"94","author":"R Njalsson","year":"2005","unstructured":"Njalsson R, Norgren S (2005) Physiological and pathological aspects of GSH metabolism. Acta Paediatr 94:132\u2013137","journal-title":"Acta Paediatr"},{"key":"9041_CR32","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1007\/s00439-005-1255-6","volume":"116","author":"R Njalsson","year":"2005","unstructured":"Njalsson R, Ristoff E, Carlsson K, Winkler A, Larsson A, Norgren S (2005) Genotype, enzyme activity, glutathione level, and clinical phenotype in patients with glutathione synthetase deficiency. Hum Genet 116:384\u2013389","journal-title":"Hum Genet"},{"key":"9041_CR33","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0006-8993(94)91429-X","volume":"635","author":"Y Oyama","year":"1994","unstructured":"Oyama Y, Hayashi A, Ueha T, Maekawa K (1994) Characterization of 2\u2032-7\u2032-dichlorofluorescin fluorescence in dissociated mammalian brain neurons: Estimation on intracellular content of hydrogen peroxide. Brain Res 635:113\u2013117","journal-title":"Brain Res"},{"key":"9041_CR34","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0076-6879(94)33041-7","volume":"233","author":"AZ Reznick","year":"1994","unstructured":"Reznick AZ, Packer L (1994) Oxidative damage to proteins: spectrophotometric method for carbonyl assay. Meth Enzymol 233:357\u2013363","journal-title":"Meth Enzymol"},{"key":"9041_CR35","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/0361-9230(84)90096-0","volume":"13","author":"GK Rieke","year":"1984","unstructured":"Rieke GK, Scarfe AD, Hunter JF (1984) l-pyroglutamate: an alternate neurotoxin for a rodent model of Huntington's Disease. Brain Res Bull 13:443\u2013456","journal-title":"Brain Res Bull"},{"key":"9041_CR36","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0014-4886(89)80008-1","volume":"104","author":"GK Rieke","year":"1989","unstructured":"Rieke GK, Smith J, Idusuyi OB, Semenya J, Howard R (1989) Chronic intrastriatal l-pyroglutamate: neuropathology and neuron sparing like Huntington's disease. Exp Neurol 104:147\u2013154","journal-title":"Exp Neurol"},{"key":"9041_CR37","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1067\/mpd.2001.114480","volume":"139","author":"E Ristoff","year":"2001","unstructured":"Ristoff E, Mayatepek E, Larsson A (2001) Long-term clinical outcome in patients with glutathione synthetase deficiency. J Pediatr 139:79\u201384","journal-title":"J Pediatr"},{"key":"9041_CR38","doi-asserted-by":"crossref","first-page":"6591","DOI":"10.1073\/pnas.90.14.6591","volume":"90","author":"JD Rothstein","year":"1993","unstructured":"Rothstein JD, Jin L, Dykes-Hoberg M, Kunet RCU (1993) Chronic inhibition of glutamate uptake produces a model of slow neurotoxicity. Proc Natl Acad Sci USA 90:6591\u20136595","journal-title":"Proc Natl Acad Sci USA"},{"key":"9041_CR39","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1023\/A:1014289232039","volume":"26","author":"AR Silva","year":"2001","unstructured":"Silva AR, Silva CG, Ruschel C, Helegda C, Wyse ATS, Wannmacher CMD, Wajner M, Dutra-Filho CS (2001) l-Pyroglutamic acid inhibits energy production and lipid synthesis in cerebral cortex of young rats in vitro. Neurochem Res 26:1277\u20131283","journal-title":"Neurochem Res"},{"key":"9041_CR40","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/BF00705812","volume":"52","author":"K Skullerud","year":"1980","unstructured":"Skullerud K, Marstein S, Schrader H, Brundelet PJ, Jellum E (1980) The cerebral lesions in a patient with generalized glutathione deficiency and pyroglutamic aciduria (5-oxoprolinuria). Acta Neuropathol 52:235\u2013238","journal-title":"Acta Neuropathol"},{"key":"9041_CR41","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0891-5849(90)90006-5","volume":"9","author":"EA Stadtman","year":"1990","unstructured":"Stadtman EA (1990) Metal ion-catalyzed oxidation of proteins: biochemical mechanism and biological consequences. Free Radic Biol Med 9:315\u2013325","journal-title":"Free Radic Biol Med"},{"key":"9041_CR42","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1023\/A:1015363220266","volume":"12","author":"P Wardman","year":"2002","unstructured":"Wardman P, Burkitt MJ, Patel KB, Lawrence A, Jones CM, Everett SA, Vojnovic B (2002) Pitfalls in the use of common luminescent probes for oxidative and nitrosative species. J Fluores 12:65\u201368","journal-title":"J Fluores"},{"key":"9041_CR43","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0076-6879(81)77046-0","volume":"77","author":"A Wendel","year":"1981","unstructured":"Wendel A (1981) Glutathione peroxidase. Meth Enzymol 77:325\u2013332","journal-title":"Meth Enzymol"}],"container-title":["Metabolic Brain Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-006-9041-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11011-006-9041-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-006-9041-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,7]],"date-time":"2021-08-07T18:22:24Z","timestamp":1628360544000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11011-006-9041-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1,20]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,2,28]]}},"alternative-id":["9041"],"URL":"https:\/\/doi.org\/10.1007\/s11011-006-9041-2","relation":{},"ISSN":["0885-7490","1573-7365"],"issn-type":[{"value":"0885-7490","type":"print"},{"value":"1573-7365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,1,20]]}}}